Supreme Court Rejects Cert Bid For CRISPR Patent Validity Ruling
WASHINGTON, D.C. — The U.S. Supreme Court on March 30 denied a petition for a writ of certiorari from a biotechnology company that told the high court that the Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article